Print Page     Close Window     
MESOBLAST LTD filed this Form 20-F on 08/31/2018
Entire Document

We are required to file or furnish reports and other information with the SEC under the Securities Exchange Act of 1934 and regulations under that act. As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the form and content of proxy statements and our officers, directors and principal shareholders are exempt from the reporting and short swing profit recovery provisions contained in Section 16 of the Exchange Act.




Subsidiary Information

For information about our subsidiaries, see “Item 18. Financial Statements – Note 12.”



Item 11.

Quantitative and Qualitative Disclosures about Market Risk

For information about our exposure to market risk and how we manage this risk, see “Item 18. Financial Statements – Note 10.”



Item 12.

Description of Securities Other than Equity Securities




Debt Securities

Not applicable.




Warrants and Rights

Not applicable.




Other Securities

Not applicable.



Copyright © 2015 Mesoblast Inc.